The FDA is offering this grant to support research into drug development tools. This grant is for external organizations, including academia and industry, to advance and qualify innovative tools that will be openly available to the wider scientific community. The FDA’s drug development tool programs provide comprehensive assistance throughout the qualification process. This includes guidance from program staff and subject matter experts through direct interactions and meetings. The research is conducted by the external grant recipients, often in collaboration with various stakeholders, ensuring the development of widely acceptable and useful tools to accelerate drug discovery and development. This grant mechanism fosters external innovation rather than a contract model.
Opportunity ID: 330294
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | FOR-FD-20-031 |
| Funding Opportunity Title: | Drug Development Tools Research Grants (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Consumer Protection Health Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.103 — Food and Drug Administration Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 25, 2021 |
| Last Updated Date: | May 25, 2021 |
| Original Closing Date for Applications: | – Archiving forecast |
| Current Closing Date for Applications: | – Archiving forecast |
| Archive Date: | May 26, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Public and State controlled institutions of higher education County governments State governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Private institutions of higher education Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) For profit organizations other than small businesses City or township governments |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: |
The drug development tool programs at FDA are created to assist the applicants to successfully complete the qualification process, and to make the qualified tools available openly. Not only the program staff but also subject matter experts from FDA are involved to guide them to create most useful and widely acceptable tools through meetings and other means of interactions with FDA. Contract mechanism is not suitable for these programs as the applications are originated from external organizations such as academia or industries, and the research is carried out by the external organizations, often in collaborations with many interested parties. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Shashi Malhotra
Grants Management Specialist Email:shashi.malhotra@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
There are no packages on this grant.
Share This Post, Choose Your Platform!
About the Author: osnqt
